[Comments on the guidelines of the European Society of Cardiology Task Force on pulmonary embolism]

MeSH terms

• Angiography
• Anticoagulants / administration & dosage
• Anticoagulants / adverse effects
• Anticoagulants / therapeutic use
• Critical Illness
• Echocardiography
• Embolectomy
• Female
• Fibrinolytic Agents / administration & dosage
• Fibrinolytic Agents / adverse effects
• Fibrinolytic Agents / therapeutic use
• Heparin / administration & dosage
• Heparin / adverse effects
• Heparin / therapeutic use
• Heparin, Low-Molecular-Weight / administration & dosage
• Heparin, Low-Molecular-Weight / adverse effects
• Heparin, Low-Molecular-Weight / therapeutic use
• Humans
• Postoperative Complications / prevention & control
• Practice Guidelines as Topic*
• Pregnancy
• Pregnancy Complications, Cardiovascular / diagnosis
• Pregnancy Complications, Cardiovascular / therapy
• Probability
• Prospective Studies
• Puerperal Disorders / diagnosis
• Puerperal Disorders / therapy
• Pulmonary Artery / diagnostic imaging
• Pulmonary Embolism / diagnosis*
• Pulmonary Embolism / diagnostic imaging
• Pulmonary Embolism / therapy*
• Radionuclide Imaging
• Risk Factors
• Sensitivity and Specificity
• Thromboembolism / prevention & control
• Thrombolytic Therapy
• Tomography, X-Ray Computed
• Vena Cava Filters